Fierce Pharma Asia—China's biotech rise; ASCO highlights; Lilly pipeline deals

The drumbeat of news regarding Asian pharma—and particularly China—continues to grow louder. At the American Society of Clinical Oncology (ASCO) meeting, Akeso took center stage with an ivonescimab presentation, and Fierce’s Angus Liu took a chance to dive into the bigger picture and symbolism behind the event. Elsewhere, calls in Washington to crack down on China biotech transactions are getting louder. Plus more.